Similar articles for PMID: 35474271

Year	Number of Results
1996	1
1997	1
1999	1
2001	3
2002	2
2003	4
2004	2
2005	5
2006	1
2007	5
2009	3
2010	2
2011	2
2013	6
2014	6
2015	1
2016	6
2017	8
2018	10
2019	8
2020	9
2021	15
2022	7

1

GWAS of Hematuria.

Gagliano Taliun SA, Sulem P, Sveinbjornsson G, Gudbjartsson DF, Stefansson K, Paterson AD, Barua M. Gagliano Taliun SA, et al. Clin J Am Soc Nephrol. 2022 Apr 26:CJN.13711021. doi: 10.2215/CJN.13711021. Online ahead of print. Clin J Am Soc Nephrol. 2022. PMID: 35474271

2

Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria.

Barua M, Paterson AD. Barua M, et al. Pediatr Nephrol. 2022 Feb;37(2):253-262. doi: 10.1007/s00467-021-04934-y. Epub 2021 Feb 26. Pediatr Nephrol. 2022. PMID: 33635378 Review.

3

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome.

Cerkauskaite A, Savige J, Janonyte K, Jeremiciute I, Miglinas M, Kazenaite E, Laurinavicius A, Strupaite-Sileikiene R, Vainutiene V, Burnyte B, Jankauskiene A, Rolfs A, Bauer P, Schröder S, Cerkauskiene R. Cerkauskaite A, et al. Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35419377 Free PMC article.

4

Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.

Buzza M, Wilson D, Savige J. Buzza M, et al. Kidney Int. 2001 May;59(5):1670-6. doi: 10.1046/j.1523-1755.2001.0590051670.x. Kidney Int. 2001. PMID: 11318937 Free article.

5

COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.

Buzza M, Wang YY, Dagher H, Babon JJ, Cotton RG, Powell H, Dowling J, Savige J. Buzza M, et al. Kidney Int. 2001 Aug;60(2):480-3. doi: 10.1046/j.1523-1755.2001.060002480.x. Kidney Int. 2001. PMID: 11473630 Free article.

6

Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.

Endreffy E, Ondrik Z, Iványi B, Maróti Z, Bereczki C, Haszon I, Györke Z, Worum E, Németh K, Rikker C, Ökrös Z, Túri S. Endreffy E, et al. Mol Cell Probes. 2011 Feb;25(1):28-34. doi: 10.1016/j.mcp.2010.10.001. Epub 2010 Oct 14. Mol Cell Probes. 2011. PMID: 20951199

7

COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.

Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M. Longo I, et al. Kidney Int. 2002 Jun;61(6):1947-56. doi: 10.1046/j.1523-1755.2002.00379.x. Kidney Int. 2002. PMID: 12028435 Free article.

8

Thin basement membrane nephropathy.

Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Savige J, et al. Kidney Int. 2003 Oct;64(4):1169-78. doi: 10.1046/j.1523-1755.2003.00234.x. Kidney Int. 2003. PMID: 12969134 Free article. Review.

9

Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.

Savige J, Harraka P. Savige J, et al. Am J Kidney Dis. 2021 Dec;78(6):857-864. doi: 10.1053/j.ajkd.2021.04.017. Epub 2021 Jul 8. Am J Kidney Dis. 2021. PMID: 34245817 Review.

10

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.

Zhang Y, Ding J, Zhang H, Yao Y, Xiao H, Wang S, Wang F. Zhang Y, et al. Mol Genet Genomic Med. 2019 May;7(5):e647. doi: 10.1002/mgg3.647. Epub 2019 Mar 18. Mol Genet Genomic Med. 2019. PMID: 30883042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed